Novartis and Alcon fined $ 345 million

news-single-imgcaption" style="width:240px;">To avoid civil proceedings, Novartis agreed to pay the United States Department of Justice (DoJ) a fine of nearly $ 234 million. (Keystone)

–

The pharmaceutical group Novartis and its former subsidiary Alcon have received sanctions from the American authorities for a cumulative amount of 345 million dollars. The facts complained of concern the entities of the two groups in Greece, Korea and Vietnam.

According to a non-prosecution act published by the US market policeman (SEC) Thursday evening, these different entities are involved in arrangements intended to offer profits to potential customers in return for the use or prescription of Novartis products or Alcon.

False books of account and registers have been kept in relation to these different programs, reports the SEC, which criticizes Novartis for not having set up sufficient internal controls either “in relation to certain aspects of the operations of these entities and affiliates “. The American regulator thus estimates that the pharmaceutical giant of the Rhine has improperly enriched himself by around 92.3 million dollars.

To avoid civil proceedings, Novartis agreed to pay the United States Department of Justice (DoJ) a fine of nearly $ 234 million. Novartis will also have to pay an additional $ 113 million to the US Treasury within two weeks, or face late payment interest. (AWP)

– .